For the best experience, please enable JavaScript in your browser settings. Their training and tasks are not for the faint-hearted. [Standard] With the dust finally ...
A Phase II trial of Recce Pharmaceutical’s topical skin infection gel has ‘exceeded expectations’, with 93% of patients achieving the primary efficacy endpoint. The Australian company’s ...